Evidence map›Paper›PMID 37622934›Full record

ArticleAudiology research2023

Neonatal Hearing Rescreening in a Second-Level Hospital: Problems and Solutions.

Marta Gómez-Delgado, Jose Miguel Sequi-Sabater, Ana Marco-Sabater, Alberto Lora-Martin, Victor Aparisi-Climent, Jose Miguel Sequi-Canet

Abstract read
In one paragraph

Article in Audiology research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Marta Gómez-DelgadoPediatric Department, Francesc de Borja University Hospital, 46702 Gandia, Spain.ORCID 0000-0003-0475-075X
Jose Miguel Sequi-SabaterRheumatology Department, La Ribera University Hospital, 46600 Alzira, Spain.
Ana Marco-SabaterPediatric Department, Francesc de Borja University Hospital, 46702 Gandia, Spain.
Alberto Lora-MartinPediatric Department, Francesc de Borja University Hospital, 46702 Gandia, Spain.
Victor Aparisi-ClimentPediatric Department, Francesc de Borja University Hospital, 46702 Gandia, Spain.ORCID 0000-0001-8523-2270
Jose Miguel Sequi-CanetPediatric Department, Francesc de Borja University Hospital, 46702 Gandia, Spain.ORCID 0000-0001-9350-8425

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Second-level hospitals face peculiarities that make it difficult to implement hearing rescreening protocols, which is also common in other settings. This study analyzes the hearing rescreening process in these kinds of hospitals. A total of 1130 individuals were included; in this cohort, 61.07% were hospital newborns who failed their first otoacoustic emission test after birth (n = 679) or were unable to perform the test (n = 11), and who were then referred to an outpatient clinic. The remaining 38.93% were individuals born in another hospital with their first test conducted in the outpatient clinic (n = 440). A high number of rescreenings were made outside of the recommended time frame, mainly in children referred from another hospital. There was a high lost-to-follow-up rate, especially regarding otolaryngologist referrals. Neonatal hearing screening at second-level hospitals is difficult because of staffing and time constraints. This results in turnaround times that are longer than recommended, interfering with the timely detection of hearing loss. This is particularly serious in outpatient children with impaired screening. Referral to out-of-town centers leads to unacceptable follow-up loss. Legislative support for all these rescreening issues is necessary. In this article, these findings are discussed and some solutions are proposed.

Indexed as

auditory potentialshearing lossneonatal hearing screeningotoacoustic emissionsrescreening

Identifiers

PMID37622934
PMCPMC10451824

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.